Phio Pharmaceuticals Corp. (PHIO)
1.18
-0.02
(-1.67%)
USD |
NASDAQ |
Aug 27, 10:45
Phio Pharmaceuticals Total Return Level : 1.20 for Aug. 26, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 26, 2026 | 1.20 |
| August 25, 2026 | 1.19 |
| August 24, 2026 | 1.17 |
| August 21, 2026 | 1.18 |
| August 20, 2026 | 1.21 |
| August 19, 2026 | 1.15 |
| August 18, 2026 | 1.05 |
| August 17, 2026 | 1.06 |
| August 14, 2026 | 1.09 |
| August 13, 2026 | 1.09 |
| August 12, 2026 | 1.08 |
| August 11, 2026 | 1.09 |
| August 10, 2026 | 1.06 |
| August 07, 2026 | 1.04 |
| August 06, 2026 | 1.06 |
| August 05, 2026 | 1.07 |
| August 04, 2026 | 1.06 |
| August 03, 2026 | 1.03 |
| July 31, 2026 | 1.025 |
| July 30, 2026 | 1.03 |
| July 29, 2026 | 0.9842 |
| July 28, 2026 | 1.01 |
| July 27, 2026 | 1.05 |
| July 24, 2026 | 1.04 |
| July 23, 2026 | 1.07 |
| Date | Value |
|---|---|
| July 22, 2026 | 1.06 |
| July 21, 2026 | 1.13 |
| July 20, 2026 | 1.08 |
| July 17, 2026 | 1.03 |
| July 16, 2026 | 0.9999 |
| July 15, 2026 | 0.8901 |
| July 14, 2026 | 1.03 |
| July 13, 2026 | 1.00 |
| July 10, 2026 | 1.02 |
| July 09, 2026 | 1.04 |
| July 08, 2026 | 1.08 |
| July 07, 2026 | 1.01 |
| July 06, 2026 | 0.99 |
| July 02, 2026 | 1.00 |
| July 01, 2026 | 1.00 |
| June 30, 2026 | 1.025 |
| June 29, 2026 | 0.985 |
| June 26, 2026 | 0.97 |
| June 25, 2026 | 0.9598 |
| June 24, 2026 | 1.02 |
| June 23, 2026 | 1.04 |
| June 22, 2026 | 1.05 |
| June 18, 2026 | 1.03 |
| June 17, 2026 | 1.08 |
| June 16, 2026 | 1.06 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Imunon, Inc. | 1.63 |
| Agenus, Inc. | 8.25 |
| Amgen, Inc. | 659.38 |
| Anika Therapeutics, Inc. | 21.68 |
| BioCryst Pharmaceuticals, Inc. | 9.83 |